C. Scalbert
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- Cutaneous Melanoma Detection and Management 1
-
- Chemotherapy-related skin toxicity 1
- Co-authors
- Laurent Mortier (3 shared papers)Philippe Marchetti (2 shared papers)Jérôme Kluza (2 shared papers)Pierre Guerreschi (2 shared papers)Pierre Formstecher (2 shared papers)Guillaume Garçon (1 shared paper)Aurélie Jonneaux (1 shared paper)Stéphane Rocchi (1 shared paper)
- Journals
- Melanoma Research (2 papers)Oncotarget (1 paper)Arthritis & Rheumatology (1 paper)Annals of the Rheumatic Diseases (1 paper)Annales de Dermatologie et de Vénéréologie (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
C. Scalbert
7 papers receiving 416 citations
Peers
Comparison fields: 5 of 63
- Oncology 224
- Genetics 44
- Immunology 59
- Cancer Research 36
- Pathology and Forensic Medicine 42
Countries citing papers authored by C. Scalbert
This map shows the geographic impact of C. Scalbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Scalbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Scalbert more than expected).
Fields of papers citing papers by C. Scalbert
This network shows the impact of papers produced by C. Scalbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Scalbert. The network helps show where C. Scalbert may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Scalbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 234 | |
| 2 | 2013 | 151 | |
| 3 | 2018 | 17 | |
| 4 | 2013 | 10 | |
| 5 | 2014 | 6 | |
| 6 | 2017 | 1 | |
| 7 | Safety of immune checkpoint inhibitors for the treatment of melanoma, bronchopulmonary and urologic neoplasms in patients with preexisting autoimmune disease | 2017 | 1 |
About C. Scalbert
C. Scalbert is a scholar working on Oncology, Dermatology, Pharmacology, Biological Psychiatry and Toxicology, having authored 7 papers that have together received 420 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Drug-Induced Adverse Reactions (2 papers), Melanoma and MAPK Pathways (2 papers), Tryptophan and brain disorders (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Computational Drug Discovery Methods (1 paper), Chemotherapy-related skin toxicity (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (224 citations), Genetics (44 citations), Immunology (59 citations), Cancer Research (36 citations) and Pathology and Forensic Medicine (42 citations). C. Scalbert has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Laurent Mortier, Philippe Marchetti, Jérôme Kluza, Pierre Guerreschi, Pierre Formstecher, Guillaume Garçon, Aurélie Jonneaux, Stéphane Rocchi, Myriam Malet‐Martino and Ariel Savina. Their work appears in journals such as Melanoma Research, Oncotarget, Arthritis & Rheumatology, Annals of the Rheumatic Diseases and Annales de Dermatologie et de Vénéréologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.